Boston Partners
CASC

Boston Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Boston Partners’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-380,143
Closed -$1.41M – 789
2017
Q4 		$1.41M Hold
380,143
– – ﹤0.01% 699
2017
Q3 		$1.56M Hold
380,143
– – ﹤0.01% 694
2017
Q2 		$1.41M Buy
+380,143
New +$1.41M ﹤0.01% 684